Skip to main content
. 2021 Feb 26;9(2):e001818. doi: 10.1136/jitc-2020-001818

Figure 3.

Figure 3

Kaplan-Meir analysis of progression-free survival (PFS) after initiation of immune checkpoint inhibitor (ICI) therapy according to use of post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis.